Pages that link to "Q36744853"
Jump to navigation
Jump to search
The following pages link to Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate. (Q36744853):
Displaying 36 items.
- LeishVet guidelines for the practical management of canine leishmaniosis (Q21198917) (← links)
- Pentavalent antimonials: new perspectives for old drugs (Q28253055) (← links)
- Dynamics and predictive potential of antibodies against insect-derived recombinant Leishmania infantum proteins during chemotherapy of naturally infected dogs (Q33817557) (← links)
- Association of liposome-encapsulated trivalent antimonial with ascorbic acid: an effective and safe strategy in the treatment of experimental visceral leishmaniasis. (Q34020450) (← links)
- Arboprotozoae (Q34086340) (← links)
- Toll receptors type-2 and CR3 expression of canine monocytes and its correlation with immunohistochemistry and xenodiagnosis in visceral leishmaniasis (Q34091014) (← links)
- Visceral leishmaniasis in Brazil: rationale and concerns related to reservoir control (Q34414084) (← links)
- Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments. (Q34980884) (← links)
- Methods of Control of the Leishmania infantum Dog Reservoir: State of the Art. (Q35101238) (← links)
- One Health: the global challenge of epidemic and endemic leishmaniasis (Q35544183) (← links)
- The Biting Midge Culicoides sonorensis (Diptera: Ceratopogonidae) Is Capable of Developing Late Stage Infections of Leishmania enriettii. (Q35772961) (← links)
- An immune-modulating diet increases the regulatory T cells and reduces T helper 1 inflammatory response in Leishmaniosis affected dogs treated with standard therapy (Q35860511) (← links)
- Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis (Q36018707) (← links)
- Directions for the diagnosis, clinical staging, treatment and prevention of canine leishmaniosis. (Q37533045) (← links)
- Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis (Q37616220) (← links)
- Management of canine leishmaniosis in endemic SW European regions: a questionnaire-based multinational survey. (Q37682896) (← links)
- Drug delivery strategies for therapy of visceral leishmaniasis (Q37702257) (← links)
- New delivery strategies for the old pentavalent antimonial drugs (Q37804399) (← links)
- Current Developments in the Therapy of Protozoan Infections (Q37883063) (← links)
- Nanomedicine and veterinary science: The reality and the practicality (Q37988213) (← links)
- Field randomized trial to evaluate the efficacy of the Leish-Tec® vaccine against canine visceral leishmaniasis in an endemic area of Brazil (Q38892536) (← links)
- Association of water extract of green propolis and liposomal meglumine antimoniate in the treatment of experimental visceral leishmaniasis. (Q39051630) (← links)
- MIXED FORMULATION OF CONVENTIONAL AND PEGYLATED MEGLUMINE ANTIMONIATE-CONTAINING LIPOSOMES REDUCES INFLAMMATORY PROCESS AND PARASITE BURDEN IN L. infantum INFECTED BALB/c MICE. (Q40085162) (← links)
- Liposomal formulations in the pharmacological treatment of leishmaniasis: a review. (Q43168913) (← links)
- Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis (Q44058897) (← links)
- Real-time PCR in clinical practice: a powerful tool for evaluating Leishmania chagasi loads in naturally infected dogs (Q44133699) (← links)
- Mixed formulation of conventional and pegylated liposomes as a novel drug delivery strategy for improved treatment of visceral leishmaniasis (Q45763061) (← links)
- Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us. (Q48259367) (← links)
- Vaccine effectiveness and use of collar impregnated with insecticide for reducing incidence of Leishmania infection in dogs in an endemic region for visceral leishmaniasis, in Brazil (Q49971449) (← links)
- Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol (Q50061923) (← links)
- Clinical management of canine leishmaniosis versus human leishmaniasis due to Leishmania infantum: Putting "One Health" principles into practice. (Q52587483) (← links)
- The diagnosis and management of a case of leishmaniosis in a dog imported to Australia. (Q54211481) (← links)
- Expression of IFN-gamma, TNF-alpha, IL-10 and TGF-beta in lymph nodes associates with parasite load and clinical form of disease in dogs naturally infected with Leishmania (Leishmania) chagasi (Q56772435) (← links)
- Unresponsiveness of Experimental Canine Leishmaniosis to a New Amphotericin B Formulation (Q57617483) (← links)
- Use of domperidone in canine visceral leishmaniasis: gaps in veterinary knowledge and epidemiological implications (Q58599631) (← links)
- Clinical and Immunological Response in Dogs Naturally Infected by L. infantum Treated with a Nutritional Supplement (Q92316327) (← links)